Synbiotic Health Announces the Expansion of their R&D and Commercial Capabilities with the Acquisition of a New Facility in Madison, Wisconsin

/in /by

Lincoln, Nebraska | November 1, 2022: Synbiotic Health, a market leader in the discovery, development, and commercialization of probiotic ingredients, announced that the company has expanded its R&D and commercial capabilities with the acquisition of a 43,000 sf facility in Madison, Wisconsin. The new facility is dedicated to the development and commercialization of advanced probiotic ingredients for improved health.

The Madison facility, which is scheduled to come online in early 2023, will focus on scale-up and development of efficient commercial processes. It is designed to complement the company’s existing facilities in Lincoln, Nebraska, which are dedicated to the discovery of new probiotic strains. The Madison facility is being constructed specifically to support probiotics in a quality-focused, GMP environment that features very low humidity levels in all areas where probiotic ingredients will be found. New lab space, which will have the capacity to accommodate numerous scientists, will allow Synbiotic Health to quickly screen new probiotics for growth and stability, thus increasing the company’s ability to introduce new high quality strains to the market.

Tim Brummels, President and CEO of Synbiotic Health, stated “This expansion of our capabilities is strategically aligned with the company’s goals. It brings our legacy of expertise in Nebraska, which is focused on discovery, to the next level. We are investing in the next phase of microbiome health: post-discovery development and commercialization that will efficiently bring products to market.”

As evidence of the cutting-edge science the company is known for, Synbiotic Health was recently honored to be named the 2022 recipient of the Governor’s Bioscience Award, presented by Nebraska Governor Pete Ricketts. The Governor’s Bioscience Award is presented annually to an individual or company that has made significant contributions to Nebraska’s bioscience industry. The selection criteria range from conducting innovative research to product development to investment that grows the bioscience community in Nebraska.

In accepting the award, Mr. Brummels added, “We are proud to be able to take some of Nebraska’s leading academic science and turn it into innovative products that are unmatched in the global probiotics industry. We expect to deliver the same high level of scientific expertise at commercial scale from our new site in Madison.”

When fully operational in 2023, the Madison site is expected to employ a workforce of up to thirty-five employees, which will include technical, operations and administrative personnel. In addition to the R&D and commercial activities that will be operational at launch, the facility is expected to expand in the future with the addition of new services and capabilities that will provide added value to the dietary supplement market.

 

About Synbiotic Health

Synbiotic Health was founded in 2018 by four microbiome research scientists to develop targeted microbiome ingredients to support health. Based on over 10 years of research, Synbiotic Health will develop and commercialize Ecologically Advanced Probiotics®  as well as rationally designed Synergistic Synbiotics®.

The foundation of Synbiotic Health’s research focuses on understanding the gut environment and its ecological framework: how probiotics and other microbiome-based ingredients interact with and influence the resident microbes in the gut. Synbiotic Health’s approach considers the entire ecosystem and the specific traits and functions necessary for microbiome-altering ingredients to perform and improve human health.

The Scientific Founder team includes Dr. Robert Hutkins and Dr. Andy Benson with the University of Nebraska-Lincoln’s Food for Health Center; Dr. Jens Walter with APC Microbiome Ireland, University College Cork; and Dr. Tom Burkey, an animal scientist with the University of Nebraska-Lincoln.

Synbiotic Health has commercialized its first two Ecologically Advanced® probiotics: the clinically studied iVS-1®  and the laboratory researched iVE-15® . Further clinical studies to demonstrate the health benefits of these novel ingredients are currently underway, with additional future studies planned for 2023 and 2024.

For more information, visit synbiotichealth.com. To arrange a press interview, please contact maria@delfino.com.

Nebraska Governor Pete Ricketts Presents Synbiotic Health with the 2022 Governor’s Bioscience Award

/in /by

Synbiotic Health is delighted to announce that its team has received the Bio Nebraska 2022 Governor’s Bioscience Award, which recognizes companies making significant contributions to the Nebraska bioscience industry. CEO Tim Brummels received this prestigious award in a presentation ceremony at Bio Nebraska’s Annual Meeting on Oct. 20, 2022, in Omaha, Nebraska.

Governor Pete Ricketts, who presented the award to Synbiotic Health, highlighted the company’s solid science: “The University of Nebraska scientists who co-founded Synbiotic Health have dedicated their careers to better understanding microbiology and food science. They’ve drawn on insights gleaned through decades of research to develop breakthrough products clinically proven to improve digestive health.”

The award’s selection criteria range from conducting innovative research to product development to investment that grows the bioscience community in Nebraska. The recipient is selected based on input from Bio Nebraska Board of Directors and the Nebraska Department of Economic Development, as well as conversations with state leaders. Synbiotic Health has been a member of Bio Nebraska since 2019.

See the official press release here.

Synbiotic Health Welcomes Kevin Hooper as Director of Business Development

/in /by

Expert in dietary supplement & nutritional product sales will have a key role in commercializing the company’s innovative products.

LINCOLN, Neb. – February 11, 2022 Microbiome-based ingredient company Synbiotic Health announces that Kevin Hooper has joined the company as Director of Business Development. Hooper has more than 14 years’ experience in sales and business development, most recently at the global ingredient supplier IFF Health. At Synbiotic Health he will work with Steve Prescott, Senior Vice President of Business Development, to implement the company’s commercialization strategy for its pipeline of innovative nutritional ingredients.

Hooper has a proven sales record and ability to identify and execute on growth opportunities while maintaining productive relationships across the dietary supplement, food & beverage, and biotechnology industries. His experience spans managing business in raw material/ingredient supply, providing sales and marketing solutions for consumer-packaged goods, and contract manufacturing. Hooper holds a degree from West Virginia University.

“Kevin’s extensive experience with probiotics and fibers will be a great asset to our team as we embark on commercialization of our first two products,” says Prescott.

“We are excited to have Kevin Hooper join our team,” adds Synbiotic Health CEO Tim Brummels. “His professional background and experience will assist us in the advancement of our Ecologically Advanced® probiotics and Synergistic Synbiotic® ingredients in key commercial markets.”


About Synbiotic Health
Synbiotic Health was founded in 2018 by four microbiome research scientists to develop targeted microbiome ingredients to support health. Based on over 10 years of research, Synbiotic Health will develop and commercialize Ecologically Advanced Probiotics® as well as rationally designed Synergistic Synbiotics®.

The foundation of Synbiotic Health’s research focuses on understanding the gut environment and its ecological framework: how probiotics and other microbiome-based ingredients interact with and influence the resident microbes in the gut. Synbiotic Health’s approach considers the entire ecosystem and the specific traits and functions necessary for microbiome-altering ingredients to perform and improve human health.

The Scientific Founder team includes Dr. Robert Hutkins and Dr. Andy Benson with the University of Nebraska-Lincoln’s Food for Health Center; Dr. Jens Walter with APC Microbiome Ireland, University College Cork; and Dr. Tom Burkey, an animal scientist with the University of Nebraska-Lincoln.

Synbiotic Health is now commercializing its first two Ecologically Advanced® probiotics: the clinically studied iVS-1® and the laboratory researched iVE-15®. Both of these strains are in additional clinical studies during 2022 to demonstrate the health benefits of these novel ingredients.

Synbiotic Health Appoints Erin Vyhlidal as VP Corporate Finance

/in /by

Experienced accountant will oversee finances as company launches first product and prepares for further growth

LINCOLN, Neb. – January 13, 2021 Microbiome-based ingredient company Synbiotic Health is pleased to announce the appointment of Erin Vyhlidal as Controller and Vice President, Corporate Finance. Vyhlidal is a CPA (inactive registrant) with twenty years’ experience in accounting. She previously oversaw a team of nine as VP Corporate Finance at Farmers National Company in Omaha, NE, after working at PricewaterhouseCoopers as a Senior Associate. Vyhlidal holds a degree from the University of Nebraska-Lincoln and completed a study abroad program at Mansfield College in Oxford, UK.

Vyhlidal’s appointment marks the first full-time hire to oversee finance and accounting at the rapidly growing company, which added a total of five new employees in 2021. Vyhlidal will work with CEO Tim Brummels to carry out tasks that include directing cash management operations, generating monthly financial reports, and completing audits and tax filings.

“We are so pleased to have recruited Erin to join our team,” says Synbiotic Health CEO Tim Brummels. “In Erin we have found local Nebraska talent that will help guide us through the pivotal year we have ahead of us, with rapid growth and the launch of new scientifically-backed products.”


About Synbiotic Health
Synbiotic Health was founded in 2018 by four well-known microbiome research scientists to develop targeted microbiome ingredients to support health. Based on over 10 years of research, Synbiotic Health will develop and commercialize Ecologically Advanced Probiotics™ as well as rationally designed Synergistic Synbiotics™..

The foundation of Synbiotic Health’s research focuses on understanding the gut environment and its ecological framework: how probiotics and other microbiome-based ingredients interact with and influence the resident microbes in the gut. Synbiotic Health’s approach considers the entire ecosystem and the specific traits and functions necessary for microbiome-altering ingredients to perform and improve human health.

The Scientific Founder team includes Dr. Robert Hutkins and Dr. Andy Benson with the University of Nebraska-Lincoln’s Food for Health Center; Dr. Jens Walter with APC Microbiome Ireland, University College Cork; and Dr. Tom Burkey, an animal scientist with the University of Nebraska-Lincoln.

Synbiotic Health is now commercializing its first ecologically-advanced probiotic – iVS-1™ Advanced Probiotic™ and is in the process of completing additional clinical studies to further define the health benefits of additional novel ingredients.

Synbiotic Health deemed “Most Innovative Probiotics and Prebiotics Development Company” in Global Health & Pharma’s annual awards

/in /by

The Synbiotic Health team is pleased to receive the award for “Most Innovative Probiotics and Prebiotics Development Company” in Global Health & Pharma Magazine’s Fitness and Nutrition Awards 2021.

According to Global Health & Pharma, the Fitness & Nutrition Awards were developed to highlight companies that “demonstrate the ability to create innovative products and concepts that can cater to the ever evolving Fitness & Nutrition industry.”

CEO Tim Brummels says, “Our team members have spent decades in academia and industry learning about probiotic and synbiotic discovery and development. We are working on truly innovative approaches and are delighted to receive this award in recognition of these efforts.”

See the company’s award profile here: https://www.ghp-news.com/winners/synbiotic-health-inc/

Synbiotic Health Team Welcomes Mallory Van Haute as Lab Scientist

/in /by

With a decade’s experience in food and microbiology, Van Haute will help execute on Synbiotic Health’s ambitious R&D program

LINCOLN, Neb.  – October 1, 2021 – Microbiome-based ingredient company Synbiotic Health welcomes team member Mallory Van Haute this week in the role of Laboratory Scientist. Van Haute brings ten years’ scientific experience in food and gastrointestinal microbiology, having worked in multiple academic laboratories at University of Nebraska – Lincoln. She has been Research Manager at the Nebraska Food for Health Center and has more than a dozen peer-reviewed publications.

In the role of Scientist at Synbiotic Health, Van Haute will report to CSO Dr. Zac Lewis and carry out research and development activities in the company’s innovation pipeline. She will lead lab work and bioinformatic projects to guide product development and deliver new health-promoting ingredients to market. She holds an M.S. in Food Science & Technology from University of Nebraska – Lincoln and is nearing completion of her Ph.D.

“Mallory has worked closely with some of our founders for many years, and brings exceptional knowledge and experience in diet-microbiome interactions to our team” says CSO Dr. Zac Lewis. “We could not be happier that she is joining us. Her presence increases our capacity to discover new ecologically advanced probiotic strains, design intelligently paired synbiotics, and rationally target the aspects of human health where our product development approach will yield superior results for consumers.

About Synbiotic Health

Synbiotic Health was founded in 2018 by four well-known microbiome research scientists to develop targeted microbiome ingredients to support health. Based on over 10 years of research, Synbiotic Health will develop and commercialize Ecologically Advanced Probiotics™ as well as rationally designed Synergistic Synbiotics™.

The foundation of Synbiotic Health’s research focuses on understanding the gut environment and its ecological framework: how probiotics and other microbiome-based ingredients interact with and influence the resident microbes in the gut. Synbiotic Health’s approach considers the entire ecosystem and the specific traits and functions necessary for microbiome-altering ingredients to perform and improve human health.

The Scientific Founder team includes Dr. Robert Hutkins and Dr. Andy Benson with the University of Nebraska-Lincoln’s Food for Health Center; Dr. Jens Walter with APC Microbiome Ireland, University College Cork; and Dr. Tom Burkey, an animal scientist with the University of Nebraska-Lincoln.

Synbiotic Health will commercialize its first ecologically-advanced probiotic – iVS-1™ Advanced Probiotic™ – in 2021 and is in the process of completing additional clinical studies to further define the health benefits of additional novel ingredients.

For more information, please contact:

Kristina Campbell

Kristina@synbiotichealth.com

Thomas Auchtung, PhD, joins Synbiotic Health as Lab Manager

/in /by

Experienced microbiologist to manage the company’s microbiome-focused research and development platform

LINCOLN, Neb.  – August 3, 2021 – Microbiome-based ingredient company Synbiotic Health is pleased to welcome Dr. Thomas Auchtung to the team in the key role of Laboratory Manager. Auchtung comes to Synbiotic Health with a wealth of microbiology research experience and scientific talent. He holds a PhD from Harvard University and joins the company after spending three years as Research Assistant Professor in the Department of Food Science and Technology at University of Nebraska-Lincoln.

Auchtung will manage internal laboratory operations and external testing to execute on the company’s product development and improvement strategy, as the company prepares to release its first commercially available ingredient, the iVS-1 Advanced Probiotic™ strain. The author of 19 peer-reviewed publications, Auchtung has previously worked in the labs of Joseph Petrosino at Baylor College of Medicine, Robert Britton at Michigan State University, Colleen Cavanaugh at Harvard University, Alan Grossman at MIT, and Robert Hausinger at Michigan State University.

“Tommy brings an impressive breadth of scientific experience from working in leading academic labs,” says Zac Lewis, CSO of Synbiotic Health. “We are delighted to have him join our growing company to help develop our unique portfolio of ecologically-designed ingredients. Having him lead our internal discovery and bench research activities will let us continue to bring truly innovative and disruptive offerings to the market for the long term. This capability will help position us as the leading science-based and data-driven strain provider in the probiotic industry; delivering demonstrably superior ecology-based technology as envisioned by our founders.”

About Synbiotic Health

Synbiotic Health was founded in 2018 by four well-known microbiome research scientists to develop ecologically-advanced microbiome ingredients for improved health. Based on over 10 years of research, Synbiotic Health will commercialize Advanced Probiotics™ as well as Synergistic Synbiotics™ – complementary combinations of probiotics with fiber and/or prebiotics.

The foundation of Synbiotic Health’s research focuses on understanding the gut environment and its ecological framework: how probiotics and other microbiome-based ingredients interact with and influence the resident microbes in the gut. Synbiotic Health’s approach considers the entire ecosystem and the specific traits and functions necessary for microbiome-altering ingredients to perform and improve human health.

The Scientific Founder team includes Dr. Robert Hutkins and Dr. Andy Benson with the University of Nebraska-Lincoln’s Food for Health Center; Dr. Jens Walter with APC Microbiome Ireland, University College Cork; and Dr. Tom Burkey, an animal scientist with the University of Nebraska-Lincoln.

Synbiotic Health will commercialize its first ecologically-advanced probiotic – iVS-1™ Advanced Probiotic™ – in 2021 and is in the process of completing additional clinical studies to further define the health benefits of additional novel ingredients.

For more information, please contact:

Kristina Campbell

Kristina@synbiotichealth.com

Synbiotic Health appoints Steve Prescott, MBA, as Senior Vice President, Business Development / Operations

/in /by

Probiotics industry veteran to lead business strategy for company’s growing product portfolio

LINCOLN, Neb.  – June 10, 2021 – Synbiotic Health, a rapidly growing microbiome nutritional ingredients company, is pleased to announce that Steve Prescott, MBA, has taken on the role of Senior Vice President, Business Development. Prescott has extensive experience in the probiotics industry, having served as Global VP – Marketing and Operations and Global Business Director for leading probiotic producers.

At Synbiotic Health, Prescott will refine and implement the company’s strategy for business operations as he oversees product development, sales and marketing. Initially he will focus on bringing the company’s first commercially available ingredient, iVS-1 Ecologically-Advanced Probiotic™, to market.

“With his broad experience in the industry, Steve Prescott is a great addition to our growing team,” said Tim Brummels, Synbiotic Health CEO. “He’s very knowledgeable about business strategy and has previously brought new products to market. Importantly, since Synbiotic Health is a company that sets itself apart through scientific innovation, his solid technical background will serve him well in this role.”Prescott previously held positions with Probi and DuPont, and has been working in the probiotics industry for 9 years. He holds an MBA from Michigan State University and a MS in Organic Chemistry from Iowa State University.

About Synbiotic Health

Synbiotic Health was founded in 2018 by four well-known microbiome research scientists to develop ecologically-advanced microbiome ingredients for improved health. Based on over 10 years of research, Synbiotic Health will commercialize advanced probiotics™ and synergistic synbiotics™ – complementary combinations of probiotics with fiber and/or prebiotics.

The foundation of Synbiotic Health’s research focuses on understanding the gut environment and its ecological framework. That is, how probiotics and other microbiome ingredients interact with and influence the resident microbes in the gut. At Synbiotic Health, its research considers the entire ecosystem and the specific traits and functions necessary for microbiome ingredients to perform and improve human health. The approach has led to novel discovery platforms as well as ecologically-advanced probiotic strains and synergistic synbiotics™.

The Scientific Founder team includes Dr. Robert Hutkins and Dr. Andy Benson with the University of Nebraska-Lincoln’s Food for Health Center; Dr. Jens Walter with APC Microbiome Ireland, University College Cork; and Dr. Tom Burkey, an animal scientist with the University of Nebraska-Lincoln.

Synbiotic Health will commercialize its first ecologically-advanced probiotic – iVS-1™ Advanced Probiotic – in 2021 and is in the process of completing additional clinical studies to further define the health benefits of additional novel ingredients.

For more information, please contact:

Tim Brummels

t.brummels@synbiotichealth.com

 

 

Zac Lewis, PhD, Joins Team at Synbiotic Health as Chief Scientific Officer

/in /by

Will lead its ‘ecologically-advanced’ microbiome research & development efforts

FOR IMMEDIATE RELEASE

LINCOLN, Neb.  – March 16, 2021 – Synbiotic Health is pleased to announce the addition of Dr. Zac Lewis as its Chief Scientific Officer. Dr. Lewis’s responsibilities will be to lead the build out and implementation of Synbiotic Health’s research & development program. Dr. Lewis will also serve as a liaison between Synbiotic Health’s Scientific Founders and its commercial efforts. A primary focus will be to develop and introduce microbiome-based ingredients using Synbiotic Health’s unique ‘ecological’ approach that has resulted in novel discovery platforms as well as ecologically-advanced probiotic strains and synergistic synbiotics™.

“We’re delighted to have Dr. Lewis join the team at Synbiotic Health,” said Tim Brummels, CEO/President with Synbiotic Health. “He brings the experience necessary to lead research efforts as well as commercialize our microbiome ingredients, and believes strongly in the value of using an ecological approach in product development.”

Dr. Lewis previously was an associate research fellow and microbiome subject matter expert with The Clorox Company working on the Renew Life brand, and has been involved in microbiome research for over 15 years. Dr. Lewis has authored or contributed to over 20 research publications and has spoken at a number of microbiome-related conferences. His key skill set includes probiotic and prebiotic product design, microbial ecology, bioinformatics, microbiology, and molecular biology. He holds a PhD in Microbiology from University of California, Davis and a BS in Microbiology from Brigham Young University.

About Synbiotic Health

Synbiotic Health was founded in 2018 by four noted microbiome research scientists to develop ecologically-advanced microbiome ingredients for improved health. Based on over 10 years of research, Synbiotic Health will commercialize advanced probiotics™ and synergistic synbiotics™ – complementary combinations of probiotics with fiber and/or prebiotics.

The foundation of Synbiotic Health’s research focuses on understanding the gut environment and its ecological framework. That is, how probiotics and other microbiome ingredients interact with and influence the resident microbes in the gut. At Synbiotic Health, its research considers the entire ecosystem and the specific traits and functions necessary for microbiome ingredients to perform and improve human health. The approach has led to novel discovery platforms as well as ecologically-advanced probiotic strains and synergistic synbiotics™.

The Scientific Founder team includes Dr. Robert Hutkins and Dr. Andy Benson with the University of Nebraska-Lincoln’s Food for Health Center; Dr. Jens Walter with APC Microbiome Ireland, University College Cork; and Dr. Tom Burkey, an animal scientist with the University of Nebraska-Lincoln.

Synbiotic Health will commercialize its first ecologically-advanced probiotic – iVS-1™ Advanced Probiotic – in 2021 and is in the process of completing additional clinical studies to further define the health benefits of additional novel ingredients.

For more information, please contact:

Tim Brummels

t.brummels@synbiotichealth.com

                                                

 

Synbiotic Health Signs Licensing Agreement to Enable Development of Unique Synergistic Synbiotics

/in /by

This is a press release from Synbiotic Health, distributed through Cision PR Newswire

LINCOLN, NE, Nov. 21, 2019 /PRNewswire/ – Synbiotics—combinations of probiotics and prebiotics—are a rapidly growing category of natural health products. However, researchers are only now beginning to study how synbiotics should be optimally formulated. Recently, Synbiotic Health announced the signing of a commercial agreement with NUtech Ventures, the nonprofit technology commercialization affiliate of the University of Nebraska, which grants the company worldwide exclusive rights to specially developed strains for use in formulating high-quality synergistic synbiotic products.

This licensing agreement emerged from research at the Nebraska Food for Health Center and University of Nebraska–Lincoln’s department of food science and technology. The technology was developed by globally leading probiotic and prebiotic researchers, including Dr. Bob Hutkins and Dr. Andy Benson of the Nebraska Food for Health Center, animal scientist Dr. Tom Burkey, and Dr. Jens Walter from the University of Alberta.

A typical synbiotic is designed to deliver the separate health benefits of its constituent probiotic and prebiotic. Synbiotic Health will now be able to formulate a new generation of products in which the probiotic microbe is selectively enriched and stimulated by the paired prebiotic substrate.

“This agreement will allow Synbiotic Health to lead the way in developing and commercializing a unique type of nutritional ingredient,” says Tim Brummels, president and CEO of Synbiotic Health. “This strong scientific foundation allows us to develop products with demonstrated synergy between the probiotic and the prebiotic. We are confident this will make the health effects more reliable, adding value for the consumer.”

The company’s first product, targeting food & beverage and nutritional supplement manufacturers, will launch in fall 2020. Its clinical program will commence in early 2020.

Brummels says, “Leading nutritional companies are considering the gut microbiome and its ability to impact human health as integral to its product development strategy. We are meeting this need head-on with scientifically robust solutions.”

Dr. Andy Benson, a University of Nebraska Presidential Chair and Director of the Nebraska Food for Health Center, says, “The agreement represents the center’s commitment to translation and commercialization of its research outputs. We hope it serves as a model to stimulate interest in bringing some of the university’s great discoveries to the marketplace.”

About Synbiotic Health

Headquartered at the Nebraska Innovation Campus, Synbiotic Health is a natural nutritional ingredients company. The founders, which include researchers at the University of Nebraska, formed Synbiotic Health in 2019, with the goal of developing scientifically- and clinically-tested synergistic combinations of probiotics with prebiotics.

Synbiotic Health aims to be the leader in the innovation and development of the highest quality synergistic synbiotics that will provide consistent health benefits as demonstrated through clinical evidence.

Visit synbiotichealth.com for information and developments.

For more information on the Nebraska Food for Health Center, visit its web site at foodforhealth.unl.edu.

SOURCE Synbiotic Health